Elron Ventures is a venture capital firm based in Tel Aviv, Israel, founded in 1962. It specializes in seed and early-stage investments, focusing primarily on sectors such as enterprise software, cybersecurity, and medical technology. The firm is committed to transforming promising ideas into global industry leaders and has a notable history of successful investments and mergers and acquisitions. Elron Ventures has played a significant role in the Israeli innovation landscape, having been a founder and early investor in a variety of companies, including those in healthcare, defense, telecommunications, and medical devices. The firm's investment strategy emphasizes opportunities within Israel, reflecting its dedication to supporting local entrepreneurial talent.
Tamnoon provides a managed cloud security remediation platform that enhances cloud security and effectively manages threats for businesses. The platform addresses misconfigurations and vulnerabilities identified by Cloud-Native Application Protection Platform (CNAPP) tools. By utilizing a combination of artificial intelligence and human expertise, Tamnoon enables organizations to remediate and prevent security issues within their cloud infrastructure. This approach allows security and development teams to streamline cloud security processes, improving overall cloud posture from initial threat detection through to resolution and prevention.
Creednz
Seed Round in 2023
Creednz specializes in developing a financial data management system and a fraud prevention platform tailored for modern corporate finance operations. The company focuses on protecting organizations from fraudulent transactions by employing advanced cyber-based techniques to analyze financial transaction data. This innovative technology enables corporations to correlate their transactions with data from internal systems, banking institutions, and real-world risk indicators. By minimizing the risk of fraud, Creednz aims to enhance the financial security and integrity of organizations, supporting Chief Financial Officers in their efforts to safeguard corporate assets.
Tamnoon
Seed Round in 2023
Tamnoon provides a managed cloud security remediation platform that enhances cloud security and effectively manages threats for businesses. The platform addresses misconfigurations and vulnerabilities identified by Cloud-Native Application Protection Platform (CNAPP) tools. By utilizing a combination of artificial intelligence and human expertise, Tamnoon enables organizations to remediate and prevent security issues within their cloud infrastructure. This approach allows security and development teams to streamline cloud security processes, improving overall cloud posture from initial threat detection through to resolution and prevention.
Entitle
Seed Round in 2023
Entitle is a developer of cloud-based software focused on improving cloud access management. The company offers a range of services that include centralized entitlement visibility, self-serve access, automated policy enforcement, and access reviews. Its platform allows for customized workflows and context-based approvals, helping security teams manage permissions effectively. Key features include granting employees timely access to resources, ensuring that admin escalations are temporary, and managing vendor permissions based on contract timelines. Additionally, Entitle facilitates access to customer data only when necessary, such as in response to support tickets. This approach enables organizations to streamline their permissions management while enhancing security and compliance.
CyVers
Funding Round in 2022
CyVers is a web 3.0 security company focused on enhancing cryptocurrency safety through advanced AI technologies. It specializes in real-time detection of cryptocurrency attacks by employing geometric machine learning to analyze both on-chain and off-chain data. The company’s platform automatically learns user behavior patterns and proactively identifies suspicious activities using anomaly detection techniques. This innovative approach aims to protect customers from potential fund theft due to illicit transactions, thereby supporting broader adoption of cryptocurrency while acting as a vital defense against decentralized finance (DeFi) hacks. Backed by top venture capitalists and AI experts, CyVers is positioned as a key player in the evolving landscape of crypto security.
Wonder Robotics
Seed Round in 2022
Wonder Robotics specializes in developing advanced autonomous systems for drones, including electric vertical take-off and landing (eVTOL) vehicles and urban air mobility (UAM) applications. The company employs sophisticated computer vision technology that mimics human visual perception, combining short-range 3D depth sensing with long-range 2D vision. This innovative approach significantly enhances a drone's ability to perceive its environment, allowing for more accurate classification and motion detection. One of its flagship products, WonderLand, enables drones to autonomously land on uncharted and unprepared sites without the need for operator supervision. It conducts complex geometric analyses using 3D sensors and proprietary algorithms to assess landing areas for obstacles and hazards, ensuring safe and precise landings. This technology not only enhances operational safety but also expands the potential applications of drones in various sectors, including commercial delivery, infrastructure inspection, and mapping.
Red Access
Series A in 2022
Red Access specializes in cybersecurity solutions with a focus on hybrid workplace environments. The company has developed an innovative agentless browsing security platform that protects devices and browsing sessions both inside and outside the office. This lightweight platform secures all browsing activities across various browsers, web applications, devices, and cloud services without requiring installations or extensions, thereby maintaining productivity. Red Access offers a unique combination of cloud and endpoint inspection, addressing browser-based threats and exploits while ensuring compatibility with existing infrastructure and user preferences. Founded by experts from the Israeli Cyber Community, Red Access is headquartered in Tel Aviv and aims to set a new standard in secure browsing with its frictionless and agnostic security solutions.
Cybersixgill
Series B in 2022
Cybersixgill specializes in providing autonomous threat intelligence solutions that enhance cyber defense for organizations by detecting and mitigating risks such as phishing, data leaks, fraud, malware, and vulnerability exploitation. Its Investigative Portal offers covert access to threat intelligence gathered from the deep and dark web, delivering context and actionable insights for effective remediation. The company's Darkfeed™ integrates seamlessly with existing security systems, proactively blocking malicious indicators of compromise (IOCs) to strengthen endpoint protection. Additionally, insights from the DVE Score™ assist in vulnerability management by predicting the immediate risk of exploitation based on the intent of threat actors. Cybersixgill serves a diverse clientele, including global enterprises, financial services, managed security service providers, and government agencies, all aiming to bolster their cyber resilience and minimize risk exposure in real-time.
Canonic Security
Seed Round in 2022
Canonic Security is a software-as-a-service (SaaS) application security platform that focuses on enhancing the security of third-party applications and integrations. The platform continuously profiles applications and user accounts, identifying suspicious or non-compliant behavior to minimize the SaaS attack surface. By providing access intelligence and insights into vulnerabilities, Canonic Security enables security teams to quickly detect SaaS-native threats and respond effectively. Its comprehensive monitoring capabilities streamline the review process for applications, allowing organizations to safely leverage the benefits of a diverse app ecosystem while mitigating risks associated with third-party access.
Sayata
Series A in 2021
Sayata is a technology company that enhances the efficiency of placing commercial risk for brokers and carriers. Its platform streamlines the quote-bind-issue process, allowing insurance professionals to complete transactions more quickly. By providing an end-to-end technological solution and educational tools, Sayata enables its partners to expand their commercial insurance portfolios effectively. Additionally, the company leverages artificial intelligence to assess risks in cyber insurance policies, integrating insights from cybersecurity experts, insurance professionals, IT developers, and data scientists. This approach helps the insurance industry mitigate risks and improve the profitability of cyber insurance offerings. Over 1,000 users across 75 brokerages and carriers currently utilize Sayata's services to enhance their operations.
Scribe Security
Seed Round in 2021
Scribe Security offers a SaaS platform that focuses on securing software within supply chains. The platform enables organizations to develop, distribute, and maintain their code while ensuring the integrity, authenticity, and reputation of code components. It provides comprehensive visibility and assurance throughout the software development life cycle, from the initial design stages to final deployment. By building and enforcing software development processes, Scribe Security helps organizations verify the provenance of their code, enhancing overall security and reliability.
Notal Vision
Series D in 2021
Notal Vision, Inc. is a diagnostic services company focused on enhancing eye disease management by providing home-based ophthalmology diagnostics. The company has developed a range of tools, including ForeseeHome, a monitoring device designed for detecting central and paracentral metamorphopsia in patients with age-related macular degeneration. It utilizes Preferential Hyperacuity Perimetry to identify subtle changes in vision. Additionally, Notal Vision offers the Notal OCT Analyzer, which employs an image analysis algorithm for the automated detection of pathological fluid in exudative retinal diseases, alongside noninvasive optical coherence tomography for imaging. Their AI-driven platform supports at-home testing and facilitates communication between patients and eye care providers. Founded in 2000, Notal Vision operates from offices in Tel Aviv, Israel, and Manassas, Virginia, and aims to improve visual outcomes by extending eye care beyond traditional clinical settings.
ZenGo
Series A in 2021
ZenGo is a developer of a non-custodial cryptocurrency wallet that aims to enhance accessibility within the global crypto economy. The company utilizes advanced multiparty computation (MPC) cryptography to ensure security by default, boasting over one million customers and a record of zero hacks. ZenGo's digital wallets enable users to buy and sell cryptocurrencies while efficiently generating and managing private keys. This innovative approach addresses issues related to security breaches and human error, allowing cryptocurrency traders and investors to manage their digital assets and investment portfolios conveniently and securely.
BrainsGate
Series F in 2020
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
Cybersixgill
Series B in 2020
Cybersixgill specializes in providing autonomous threat intelligence solutions that enhance cyber defense for organizations by detecting and mitigating risks such as phishing, data leaks, fraud, malware, and vulnerability exploitation. Its Investigative Portal offers covert access to threat intelligence gathered from the deep and dark web, delivering context and actionable insights for effective remediation. The company's Darkfeed™ integrates seamlessly with existing security systems, proactively blocking malicious indicators of compromise (IOCs) to strengthen endpoint protection. Additionally, insights from the DVE Score™ assist in vulnerability management by predicting the immediate risk of exploitation based on the intent of threat actors. Cybersixgill serves a diverse clientele, including global enterprises, financial services, managed security service providers, and government agencies, all aiming to bolster their cyber resilience and minimize risk exposure in real-time.
Zengold
Angel Round in 2019
Shenzhen ZenGold Culture Development Co., LTD. operates in the field of blockchain technology, specifically focusing on the trading and management of gold assets. The company has developed a decentralized application that utilizes blockchain to facilitate gold spot trading, providing users with real-time price quotes sourced from the Shanghai Gold Exchange. ZenGold also offers custody services for physical gold assets and enables delivery options. The physical assets are underwritten by Sunshine Insurance Company, ensuring security and reliability for users in China and beyond.
Sayata
Seed Round in 2019
Sayata is a technology company that enhances the efficiency of placing commercial risk for brokers and carriers. Its platform streamlines the quote-bind-issue process, allowing insurance professionals to complete transactions more quickly. By providing an end-to-end technological solution and educational tools, Sayata enables its partners to expand their commercial insurance portfolios effectively. Additionally, the company leverages artificial intelligence to assess risks in cyber insurance policies, integrating insights from cybersecurity experts, insurance professionals, IT developers, and data scientists. This approach helps the insurance industry mitigate risks and improve the profitability of cyber insurance offerings. Over 1,000 users across 75 brokerages and carriers currently utilize Sayata's services to enhance their operations.
Alcide
Series A in 2018
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.
ZenGo
Seed Round in 2018
ZenGo is a developer of a non-custodial cryptocurrency wallet that aims to enhance accessibility within the global crypto economy. The company utilizes advanced multiparty computation (MPC) cryptography to ensure security by default, boasting over one million customers and a record of zero hacks. ZenGo's digital wallets enable users to buy and sell cryptocurrencies while efficiently generating and managing private keys. This innovative approach addresses issues related to security breaches and human error, allowing cryptocurrency traders and investors to manage their digital assets and investment portfolios conveniently and securely.
Nitinotes
Series A in 2018
NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.
Alcide
Seed Round in 2017
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.
Audioburst
Series A in 2017
Audioburst Ltd. is an audio content search and discovery platform that utilizes artificial intelligence to make radio, TV, podcasts, and other media searchable in real-time. Founded in 2015 and headquartered in Palo Alto, California, with additional offices in Tel Aviv, Israel, and Tokyo, Japan, Audioburst enables users to access customized audio content based on their preferences and listening habits. The company offers several services, including the Audioburst Creators platform, which provides tools for transcribing, editing, amplifying, and monetizing audio content; Audioburst Studio, designed for integrating audio playlists into existing applications; and Audioburst Auto, an Android app that delivers tailored playlists and hands-free voice search for drivers. Through these offerings, Audioburst connects listeners to a vast library of audio content while collaborating with creators to enhance the listening experience across various devices.
Nitinotes
Seed Round in 2016
NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.
Alcide
Seed Round in 2016
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.
Cybersixgill
Series A in 2016
Cybersixgill specializes in providing autonomous threat intelligence solutions that enhance cyber defense for organizations by detecting and mitigating risks such as phishing, data leaks, fraud, malware, and vulnerability exploitation. Its Investigative Portal offers covert access to threat intelligence gathered from the deep and dark web, delivering context and actionable insights for effective remediation. The company's Darkfeed™ integrates seamlessly with existing security systems, proactively blocking malicious indicators of compromise (IOCs) to strengthen endpoint protection. Additionally, insights from the DVE Score™ assist in vulnerability management by predicting the immediate risk of exploitation based on the intent of threat actors. Cybersixgill serves a diverse clientele, including global enterprises, financial services, managed security service providers, and government agencies, all aiming to bolster their cyber resilience and minimize risk exposure in real-time.
IRONSCALES
Seed Round in 2016
Ironscales Ltd. is a cybersecurity company that specializes in phishing mitigation solutions aimed at protecting organizations from cyber attacks. Founded in 2013 and headquartered in Kfar Saba, Israel, the company offers a comprehensive platform that combines machine learning and human intelligence to address the challenges of email phishing. Its services include phishing simulation training, real-life spear-phishing campaigns, automated incident response, and analysis reports. The platform is designed to engage employees through gamified training experiences, fostering a proactive approach to cybersecurity by assessing and reducing susceptibility to phishing attempts. Ironscales enables corporate information security officers to create a human-based intrusion prevention system, enhancing the overall security posture of enterprises.
Coramaze Technologies
Series A in 2015
Coramaze Technologies is a medical device company focused on developing innovative solutions for heart diseases. Founded in 2013 and headquartered in Munich, Germany, the company is working on a minimally invasive valve repair system aimed at treating patients with structural heart valve diseases. Their flagship product, the Mitramaze valve repair system, is a catheter-based device designed for implantation directly into the beating heart, catering to inoperable and asymptomatic patients. Additionally, Coramaze is advancing an adaptive tricuspid valve repair device known as Tripair, which is designed to be anchored in the right atrium, facilitating a quick and straightforward procedure accessible in catheterization labs. This technology aims to address functional mitral regurgitation resulting from heart enlargement due to conditions like heart attacks or heart failure, thus providing less invasive treatment options for patients who might otherwise go without proper care.
POCARED Diagnostics
Venture Round in 2015
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.
CartiHeal
Series D in 2015
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
BrainsGate
Venture Round in 2015
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
POCARED Diagnostics
Series G in 2014
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.
CartiHeal
Venture Round in 2013
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
POCARED Diagnostics
Series F in 2013
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.
CartiHeal
Venture Round in 2012
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
CartiHeal
Series D in 2012
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
BrainsGate
Series C in 2011
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
CartiHeal
Series C in 2011
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
POCARED Diagnostics
Series F in 2011
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.
BPT
Series B in 2009
BPT is developing and commercializing advanced membranes-based separation solutions addressing the unique needs of the water and wastewater treatment for key industrial processes. BPT patented chemically-stable membrane technology enable customers in the landfill, mining, chemical, biopharma and food industries to comply with the environmental regulations, reuse water and reduce production costs. BPT membranes are field proven to enable lowest cost reclamation of some of the most aggressive and vexing industrial waste water streams.
CartiHeal
Series A in 2009
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
PLYmedia
Series A in 2009
PLYmedia, Inc. is an ad-tech company established in 2006 and headquartered in Palo Alto, California. The company focuses on creating performance-based advertising solutions, primarily through its flagship product, PLYexchange, which integrates a highly accurate prediction engine and real-time bidding (RTB) capabilities. PLYmedia also offers PLYvideo, a specialized video advertising solution for ad networks and agencies, and Adk2, a customizable performance-based ad exchange. These products are designed to enhance the performance of internet advertising while safeguarding advertisers and publishers from low-quality supply and demand. By collaborating with ad networks, PLYmedia aims to build a global ecosystem centered on performance-driven advertising.
BrainsGate
Series C in 2008
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
ChipX
Series B in 2008
ChipX, Inc. is a Mixed-Signal ASIC company with the broadest offering of value-added ASIC solutions, including Standard Cell, Structured ASIC and Hybrid ASIC technology. ChipX has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores; all are silicon proven and certified and they can be integrated in customers’ ASICs with a record first-time to market success. ChipX products are widely used in industrial applications, medical equipment and military/aerospace systems. Headquartered in Santa Clara, CA, ChipX is a privately held corporation, with a Research and Development subsidiary in Israel.
Aqwise
Venture Round in 2008
Aqwise - Wise Water Technologies Ltd. is a prominent provider of innovative wastewater treatment solutions catering to both industrial and municipal markets. The company specializes in enhancing the biological oxygen demand (BOD) and nutrient removal capacities of wastewater treatment plants, leading to improved efficiency in the use of existing reactors and the implementation of new systems. Aqwise offers a comprehensive range of services, from basic process packages to full turnkey project design, construction, and operational support. Its technology aids various industries, including paper, food and beverage, and chemicals, in addressing challenges related to water scarcity, pollution, and regulatory compliance. By providing effective solutions, Aqwise helps clients minimize their environmental impact while achieving lower investment and operational costs.
Safend
Series C in 2008
Safend specializes in Data Leakage Prevention (DLP) solutions aimed at safeguarding enterprise endpoints from data loss, misuse, and theft. Its flagship product, the Safend Data Protection Suite, operates on a streamlined architecture that includes a single server, management console, and agent. The suite comprises several modular components: Safend Encryptor for encrypting internal hard drives, Safend Protector for controlling ports and external media, Safend Inspector for monitoring and blocking sensitive content transfers, Safend Discoverer for mapping and classifying sensitive data, Safend Reporter for compliance reporting, and Safend Auditor for auditing connected devices and networks. The company serves a diverse clientele, including governmental agencies, healthcare organizations, and businesses in finance and retail, helping them adhere to regulations such as HIPAA, PCI, and SOX. Safend distributes its products globally through a network of resellers and partners, focusing on security-conscious organizations.
Medingo Medical Solutions
Venture Round in 2007
Medingo develops and produces miniature medical devices for people with diabetes. The company's flagship product is the Solo MicroPump, a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or needles. The company was founded in 2005 and is based in Yoqneam Illit, Israel and the US Corporate Office is in Tampa, FL.
Enure Networks
Venture Round in 2007
Enure Networks, Ltd. specializes in home-network management and self-healing software solutions designed to enhance the installation and maintenance of home and small office/home office (SOHO) networked services. The company provides a range of solutions, including high-speed internet for home users, VoIP services that manage performance and connectivity, security solutions that proactively address potential risks, and IPTV solutions that simplify the complexities of IPTV delivery. Enure Networks also offers a True Information & Control server that facilitates the management of data and actions related to home networks. Founded in 2003 and based in Herzeliya, Israel, the company has operations in the United States and Europe, aiming to deliver seamless broadband services for service providers.
MuseStorm
Series A in 2007
MuseStorm school is a fantastic opportunity to advance their professional career. The MUSEstorm IT School offers life-changing opportunities.
POCARED Diagnostics
Venture Round in 2007
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.
RADLIVE
Series A in 2007
Founded in 2005, RADLIVE develops high definition telephony technologies, products and applications. RADLIVE's innovative solutions and unique technology will transform the way users and organizations all over the world communicate and collaborate with each other. RADLIVE is a member of the RAD Group, a collection of independent companies that develop, manufacture and market solutions for diverse segments of the networking and telecommunications industry. Closed February 2010.
Journeys
Seed Round in 2007
Journeys, based in Israel, is a both a virtual world and MMOG (Massively Multiplayer Online Game). Journeys is a participant at the 2008 IsraelWebTour.
BPT
Series A in 2007
BPT is developing and commercializing advanced membranes-based separation solutions addressing the unique needs of the water and wastewater treatment for key industrial processes. BPT patented chemically-stable membrane technology enable customers in the landfill, mining, chemical, biopharma and food industries to comply with the environmental regulations, reuse water and reduce production costs. BPT membranes are field proven to enable lowest cost reclamation of some of the most aggressive and vexing industrial waste water streams.
Enure Networks
Series A in 2006
Enure Networks, Ltd. specializes in home-network management and self-healing software solutions designed to enhance the installation and maintenance of home and small office/home office (SOHO) networked services. The company provides a range of solutions, including high-speed internet for home users, VoIP services that manage performance and connectivity, security solutions that proactively address potential risks, and IPTV solutions that simplify the complexities of IPTV delivery. Enure Networks also offers a True Information & Control server that facilitates the management of data and actions related to home networks. Founded in 2003 and based in Herzeliya, Israel, the company has operations in the United States and Europe, aiming to deliver seamless broadband services for service providers.
Safend
Series B in 2006
Safend specializes in Data Leakage Prevention (DLP) solutions aimed at safeguarding enterprise endpoints from data loss, misuse, and theft. Its flagship product, the Safend Data Protection Suite, operates on a streamlined architecture that includes a single server, management console, and agent. The suite comprises several modular components: Safend Encryptor for encrypting internal hard drives, Safend Protector for controlling ports and external media, Safend Inspector for monitoring and blocking sensitive content transfers, Safend Discoverer for mapping and classifying sensitive data, Safend Reporter for compliance reporting, and Safend Auditor for auditing connected devices and networks. The company serves a diverse clientele, including governmental agencies, healthcare organizations, and businesses in finance and retail, helping them adhere to regulations such as HIPAA, PCI, and SOX. Safend distributes its products globally through a network of resellers and partners, focusing on security-conscious organizations.
BrainsGate
Venture Round in 2005
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
Teledata Networks
Venture Round in 2005
Teledata Networks is a leading global provider of innovative Access Network solutions and products for telecom service providers. The company creates solutions that enable a smooth migration path to Next Generation Networks (NGN) and support a full Triple Play service portfolio.
ChipX
Venture Round in 2004
ChipX, Inc. is a Mixed-Signal ASIC company with the broadest offering of value-added ASIC solutions, including Standard Cell, Structured ASIC and Hybrid ASIC technology. ChipX has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores; all are silicon proven and certified and they can be integrated in customers’ ASICs with a record first-time to market success. ChipX products are widely used in industrial applications, medical equipment and military/aerospace systems. Headquartered in Santa Clara, CA, ChipX is a privately held corporation, with a Research and Development subsidiary in Israel.
ForeseeHome
Series A in 2003
Notal Vision is developing the first comprehensive diagnostic solution for the early detection and frequent monitoring of Age-Related Macular Degeneration (AMD), the leading cause of blindness in the western world today. Early detection of ARM can allow doctors to treat patients at an earlier stage and possibly prevent any loss of sight. A true pioneer in the eye care industry, Notal Vision has developed and introduced the first home-based monitoring system for AMD patients, the ForeseeHome™ AMD Monitoring Program.
Chip Express
Venture Round in 2002
Fit the CHIP Express™ digital diesel tuning box for more torque too. You'll immediately notice better acceleration from low down in the rev range and when using taller gears. And that means more pulling power - precisely what you need if you tow a caravan, a horse box, a boat or if you drive a heavily laden vehicle like a van or pickup.
Mediagate
Venture Round in 2000
mediagate develops and sells iPost Universal Messaging, a carrier-class universal messaging solution. iPost Universal Messaging is comprised of iPost application software and carrier-grade, third-party hardware. iPost Universal Messaging enables subscribers to manage multi-media messages, voice, fax, email and page, from within a single mailbox using any email client (Outlook, Hotmail, Netscape Mail, Eudora, etc.), from anywhere in the world, any time of the day or week. Subscribers can use any telephone, mobile phone, PDA, computer, laptop, fax machine, and WAP and SMS-enabled device to manage their messages.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.